Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

Alembic Pharma received the final approval from the USFDA for its abbreviated new drug application (ANDA) for Carbamazepine ...

Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...